DailyDoctor Archive Specialties Get app
All top clinical updates briefings

The edition · Top Clinical Updates

Seven days of antibiotics matches four weeks in bone infection, and surveillance colonoscopy at five years matches three

Two noninferiority trials shorten long-standing regimens; blinatumomab replacing two chemotherapy cycles lifts four-year event-free survival in high-risk childhood leukaemia by 13 percentage points; a maternal high egg and peanut diet does not prevent infant allergy; and head elevation after thrombectomy remains unproven.

The edition in brief

SOLARIO randomised 500 adults after surgery for orthopaedic infection, all of whom had a local antibiotic carrier implanted, to systemic antibiotics for at least four weeks or no more than seven days. Definite treatment failure at 12 months was 14.1% with the long course and 11.1% with the short one, meeting noninferiority; treatment-related symptoms by week six were 45.2% versus 17.2%. In AIEOP-BFM ALL 2017, 709 children with high-risk B-cell acute lymphoblastic leukaemia were randomised to two cycles of blinatumomab or two cycles of chemotherapy after consolidation: four-year event-free survival was 83.0% versus 70.3% (HR 0.51, 95% CI 0.35-0.73), with treatment-related infection in 23.9% versus 69.4% and neurotoxic events in 12.0% versus 3.2%. PrEggNut randomised 2,137 pregnant women whose babies had a strong family history of allergy to a high or standard egg and peanut diet from before 23 weeks' gestation to four months postnatally; IgE-mediated egg or peanut allergy at one year was 7.8% versus 8.4% (RR 0.93, 95% CI 0.69-1.26). HeadSOAR randomised 1,368 patients in China to 72 hours of head elevation or flat positioning after successful thrombectomy, with no significant difference in 90-day modified Rankin shift (adjusted generalised OR 1.12, 95% CI 0.97-1.29). The edition closes on EPoS II, in which starting surveillance colonoscopy five years after high-risk adenoma removal was noninferior to three years at interim analysis.

In this edition
01
Clinical update

Seven days of systemic antibiotics after bone and joint infection surgery matched four weeks or more

After orthopaedic infection surgery with a local antibiotic carrier, seven days of systemic antibiotics is enough — and spares most of the treatment-related harm of four weeks.

2 min · The New England journal of medicineRead →
Primary outcome
definite treatment failure by 12 months
Effect
14.1% (long, 4 weeks or more) vs 11.1% (short, 7 days or fewer); risk difference -3.0 percentage points (95% CI -9.0 to 3.0), within a 10-point noninferiority margin
02Clinical update

Swapping two chemotherapy cycles for blinatumomab lifted four-year event-free survival from 70% to 83% in high-risk childhood leukaemia

In high-risk paediatric B-cell ALL, replacing two chemotherapy cycles with blinatumomab improved four-year event-free survival by about 13 percentage points and cut treatment-related infection to a third.

2 min · The New England journal of medicineRead →
03Research

Eating more egg and peanut in pregnancy did not prevent infant allergy

Advise normal egg and peanut intake in pregnancy; loading the maternal diet does not protect the infant, and the prevention that works happens after birth.

2 min · The New England journal of medicineRead →
04Research

Head elevation after thrombectomy: no significant benefit, but the trial cannot close the question

Head position after successful thrombectomy is not settled — continue local protocol, and do not present flat or elevated positioning to families as evidence-based.

2 min · BMJ (Clinical research ed.)Read →
05Pearl

Write a stop date on the antibiotic prescription, not a duration

Prescribe antibiotics with a calendar stop date rather than a number of days; durations drift longer at every handover, dates do not.

1 minRead →
06
Practice changer

Surveillance colonoscopy at five years after high-risk adenoma removal was noninferior to three

For high-risk adenomas as defined here, a first surveillance colonoscopy at five years rather than three is supported — and the released capacity belongs to symptomatic patients.

2 min · The New England journal of medicineRead →
Primary outcome
cumulative incidence of colorectal cancer (10 years at final analysis; 5 years reported here)
Effect
0.77% with first surveillance at 5 years vs 0.82% at 3 years; difference -0.05 percentage points, upper boundary of the 99.12% CI 0.68 against a 0.7-point margin

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for top clinical updates, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free